Antibiotic Trial Without Comparator Would Lower R&D Cost, Wyeth Exec Says

Antibiotic trials without comparator drug arms would lower development costs, Wyeth Antibacterial Research Director Steven Projan, PhD, suggested

More from Archive

More from Pink Sheet